FUSED HETEROCYCLIC COMPOUNDS AS SODIUM CHANNEL MODULATORS
申请人:Gilead Sciences, Inc.
公开号:EP2707361B1
公开(公告)日:2017-08-23
US9115096B2
申请人:——
公开号:US9115096B2
公开(公告)日:2015-08-25
US9403782B2
申请人:——
公开号:US9403782B2
公开(公告)日:2016-08-02
US9682998B2
申请人:——
公开号:US9682998B2
公开(公告)日:2017-06-20
[EN] FUSED HETEROCYCLIC COMPOUNDS AS SODIUM CHANNEL MODULATORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES CONDENSÉS UTILISÉS COMME MODULATEURS DES CANAUX SODIQUES
申请人:GILEAD SCIENCES INC
公开号:WO2012154760A1
公开(公告)日:2012-11-15
The present disclosure relates to compounds that are sodium channel inhibitors and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the compounds is given by Formula (I), wherein Q, R1, X1, X2, Y and R2 are as described herein, to methods for the preparation and use of the compounds and to pharmaceutical compositions containing the same.